Search Results

Clinical Harms Review Additional detail for Service Level SOP (S130)

This document should be read in conjunction with the overarching DCHS Standard Operating procedure on Clinical Harms which outlines the processes to be followed to deliver a consistent approach to: • Utilising a proactive method of risk stratification to minimise clinical harm as a result of delays in care. • Embedding systems which consider health inequalities. • Monitoring waiting times against defined thresholds across pathways of care. • Delivering personalised, patient-centred communications to patients who are waiting for care. • Implementing Harm Reviews for the that support the Trusts governance and assurance processes and maintains practice in line with national expectations.

A3 - SBARD Structured Communication Tool

Disclosure Ref 2024153 - 65 week wait for elective treatment .pdf

Disclosure Ref 2025151 - Trust buying and supplying paracetamol and Ibuprofen.pdf

FOI disclosure ref 2025/151 regarding the Trust purchasing and supplying Paracetamol and ibuprofen

Doxycycline Post-exposure Prophylaxis (doxyPEP) National Template

Your Health Records Leaflet - updated Jan 2019.pdf

FINAL Chief Executive Designate - Stakeholder Briefing - 11 November 2021.pdf

Dr Chris Clayton appointment; Chief Executive JUCD

Appendix 4 - List of CDs which Require Denaturing and Witnessed Destruction (S47)

Appendix 4 - List of CDs which Require Denaturing and Witnessed Destruction (S47)

Disclosure Ref 202281 - Staff Absence data Dec 2021 - Jan 2022.pdf

FOI disclosure

A2a - DEPRIVATION OF LIBERTY SAFEGUARDS FORM 1 (P35)

Safeguarding Form 1,P35,DoLs